sur AMOEBA (EPA:ALMIB)
AXPERA awarded for its innovation in biocontrol
Amoéba, a French greentech company, has won the Bernard Blum Award 2025 Gold Medal for its AXPERA biocontrol solution. This award recognizes the company's innovation in combating fungal plant diseases. AXPERA stands out for its pioneering use of amoebae, offering a sustainable alternative to traditional chemical treatments.
This global recognition highlights Amoéba's commitment to developing environmentally friendly technologies spanning more than a decade. The solution has been tested on a variety of crops, particularly in Europe and the United States, demonstrating its effectiveness and reliability in real-world conditions.
In the United States, AXPERA has obtained approval from the US EPA, and efforts are underway in Europe and Brazil to expand its commercialization. These advances confirm AXPERA's potential to become a global benchmark in biocontrol.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de AMOEBA